ArticlePLoS neglected tropical diseases2026
Assessment of the role of Haemophilus ducreyi coinfection on outcomes of Yaws treatment in the southwestern part of Ghana.
Article in PLoS neglected tropical diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundYaws, caused by Treponema pallidum subsp. pertenue (TP) is targeted for eradication by 2030 under the World Health Organization's (WHO) initiative, which relies on mass drug administration (MDA) of azithromycin. Evidence of persistent lesions after treatment has been reported. While the occurrences of Haemophilus ducreyi (HD) in yaws-like lesions has been widely documented, there is limited evidence regarding its influence on treatment outcomes assessed at the WHO-recommended 4-week follow-up. In this study, we sought to detect the occurrence of H. ducreyi in yaws-confirmed cases and assess its influence on treatment outcomes. METHODOLOGY: We conducted a prospective cohort study of school children from Wassa Amenfi East and Aowin Districts in Ghana. A total of 46 Dual Path Platform (DPP) positive yaws cases were subjected to PCR analysis to determine the aetiological agents, including T. pallidum and/or H. ducreyi. Treatment was with a single dose of oral azithromycin and outcomes were evaluated 4 weeks post-treatment, assessing clinical resolution and time to healing, with results stratified by the identified aetiological agents.
findingsOf the 46 participants tested, 18/46 (39%) were positive for HD, 6 (13%) were TP positive, 3 (7%) were positive for TP/HD, and 19 (41%) were negative for both pathogens tested. Healing rate was 80.4% (95% Confidence Interval [CI], 73.9-95.5) for all cases; 72.2% (95% CI: 57.0-93.4) for HD only, 83.3% (95% CI: 43.6-97.0) for TP only, 100% (95% CI: 43.9-100) for TP/HD, and 84.2% (95% CI: 62.4-94.5) for negative cases. Complete healing was generally observed by day 15-20.
conclusionThese results support the ongoing use of a single dose azithromycin in yaws elimination programmes, as evidenced by the healing rates observed. Nonetheless, greater focus should be directed toward improving diagnostic and treatment approaches for individual patients. Further research is necessary to better understand the aetiology of cutaneous ulcers in yaws-endemic regions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.